FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Positive data from oral therapy designed to improve muscle function and body composition
Pilot project between BioCytics and LIDE Biotech
IASO acquires cell therapy company MediSix
Jazz Pharmaceuticals to acquire Actio Biosciences and expand rare epilepsy portfolio
Tagomics introduces cfDNA-based blood test for multi-organ drug safety monitoring
Base to Base biotech podcast 71: The IgA/CD89 axis
Activating human killer T-cells against cancer
Spinal Muscular Atrophy Awareness Month begins with spotlight on care gaps
University of Aberdeen-led team to trial new drug for heavy menstrual bleeding